IceCure Medical Reports FY GAAP EPS of -$0.24, Revenue Increases 2.7% YoY to $3.38M

IceCure Medical reported FY GAAP EPS of -$0.24 and revenue of $3.38M, a 2.7% YoY increase. The company's revenue for the twelve months ended December 31, 2025, increased to $3,379,000 from $3,291,000 for the twelve months ended December 31, 2024, which included the recognition of $100,000 from a distribution agreement.